Accumulating evidence points to physicians’ growing comfort with prescribing biosimilars. A newly published study from the Journal of Managed Care and Specialty Pharmacy, based on a 2023 survey, found that physicians treating immunologic disorders were “likely” or “very likely” to prescribe a biosimilar for a new start patient as well as to recommend biosimilars for … Continue reading With Experience and Coverage, Physician Comfort With Immunology Biosimilars Increases